Lincoln Pharmaceuticals (NSE:LINCOLN) Change In Inventory: ₹0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LINCOLN Lincoln Pharmaceuticals Ltd NSE:LINCOLN
82 GF Score
Price ₹609.65
GF Value ₹717.79
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lincoln Pharmaceuticals Change In Inventory?

Lincoln Pharmaceuticals NSE:LINCOLN +0.48% 82 Change In Inventory is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:LINCOLN with a GF Score™ of 82/100 and a GF Value™ of ₹717.79 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Lincoln Pharmaceuticals's change in inventory for the quarter that ended in Jun. 2026 was ₹0 Mil. It means Lincoln Pharmaceuticals's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Lincoln Pharmaceuticals's change in inventory for the fiscal year that ended in Mar. 2026 was ₹-14 Mil. It means Lincoln Pharmaceuticals's inventory increased by ₹14 Mil from Mar. 2025 to Mar. 2026 .

Lincoln Pharmaceuticals's Total Inventories for the quarter that ended in Jun. 2026 was ₹0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Lincoln Pharmaceuticals's Days Inventory for the quarter that ended in Jun. 2026 was 42.93.

Inventory Turnover measures how fast the company turns over its inventory within a year. Lincoln Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2026 was 2.13.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lincoln Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.23.

Lincoln Pharmaceuticals  (NSE:LINCOLN) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lincoln Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=400.528/851.431*365 / 4
=42.93

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lincoln Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=851.431 / 400.528
=2.13

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lincoln Pharmaceuticals's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=400.528 / 1772.821
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lincoln Pharmaceuticals Change In Inventory Related Terms

Lincoln Pharmaceuticals Change In Inventory Historical Data

* Premium members only.

The historical data trend for Lincoln Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lincoln Pharmaceuticals Change In Inventory Chart

Lincoln Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -261.29 27.14 -71.40 -15.09 -14.28

Lincoln Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:LINCOLN
82GF Score
Lincoln Pharmaceuticals Ltd NSE:LINCOLN
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lincoln Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of ₹0 Mil mean?
Lincoln Pharmaceuticals (NSE:LINCOLN) has a Change In Inventory of ₹0 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Lincoln Pharmaceuticals and its competitors.
Is Lincoln Pharmaceuticals' Change In Inventory too high?
Lincoln Pharmaceuticals' current Change In Inventory is ₹0 Mil. Overall, Lincoln Pharmaceuticals has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lincoln Pharmaceuticals' Change In Inventory compare to ZTS?
Lincoln Pharmaceuticals' Change In Inventory of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Lincoln Pharmaceuticals and its competitors. Lincoln Pharmaceuticals's current Change In Inventory is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lincoln Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lincoln Pharmaceuticals (NSE:LINCOLN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹717.79, compared to a current price of ₹609.65 — trading 15.1% below its estimated fair value. The current Change In Inventory is ₹0 Mil. Lincoln Pharmaceuticals' overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Lincoln Pharmaceuticals (NSE:LINCOLN), the current Change In Inventory is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lincoln Pharmaceuticals (NSE:LINCOLN) Overvalued in 2026?

Based on GuruFocus' analysis, Lincoln Pharmaceuticals stock appears to be undervalued. The current stock price of ₹609.65 is trading 15.1% below its estimated GF Value™ of ₹717.79. GuruFocus considers Lincoln Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NSE:LINCOLN:

  • Change In Inventory: ₹0 Mil
  • GF Value™: ₹717.79 vs. price of ₹609.65 (15.1% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the NSE:LINCOLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lincoln Pharmaceuticals Business Description

Other Exchanges 531633:India
Address Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
82GF Score

Get the complete analysis for NSE:LINCOLN

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹609.65
Price
₹717.79
GF Value